94 related articles for article (PubMed ID: 17128826)
1. [Human defensins: prophylaxis and therapy against HIV?].
Prado-Montes de Oca E
Gac Med Mex; 2006; 142(5):431-3. PubMed ID: 17128826
[TBL] [Abstract][Full Text] [Related]
2. Defensins: antimicrobial peptides for therapeutic development.
Verma C; Seebah S; Low SM; Zhou L; Liu SP; Li J; Beuerman RW
Biotechnol J; 2007 Nov; 2(11):1353-9. PubMed ID: 17886240
[TBL] [Abstract][Full Text] [Related]
3. Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents.
Kruse T; Kristensen HH
Expert Rev Anti Infect Ther; 2008 Dec; 6(6):887-95. PubMed ID: 19053901
[TBL] [Abstract][Full Text] [Related]
4. Role of antimicrobial peptides in host defense against mycobacterial infections.
Méndez-Samperio P
Peptides; 2008 Oct; 29(10):1836-41. PubMed ID: 18582513
[TBL] [Abstract][Full Text] [Related]
5. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
6. Microbicides for multidrug-resistant and multitropic HIV-1.
D'Cruz OJ; Uckun FM
Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
[TBL] [Abstract][Full Text] [Related]
7. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
Nikolic DS; Garcia E; Piguet V
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
[TBL] [Abstract][Full Text] [Related]
8. Diverse functions of defensins and other antimicrobial peptides in periodontal tissues.
Dommisch H; Jepsen S
Periodontol 2000; 2015 Oct; 69(1):96-110. PubMed ID: 26252404
[TBL] [Abstract][Full Text] [Related]
9. Defensin-based anti-infective strategies.
Wilmes M; Sahl HG
Int J Med Microbiol; 2014 Jan; 304(1):93-9. PubMed ID: 24119539
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of antifungal plant and insect defensins.
Thevissen K; Kristensen HH; Thomma BP; Cammue BP; François IE
Drug Discov Today; 2007 Nov; 12(21-22):966-71. PubMed ID: 17993416
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
Cole AM; Cole AL
Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
[TBL] [Abstract][Full Text] [Related]
12. New microbicides enter trials in United States.
AIDS Alert; 2005 Jan; 20(1):10-1. PubMed ID: 15717357
[TBL] [Abstract][Full Text] [Related]
13. [Defensins in chronic inflammatory diseases].
Schindler B
Med Monatsschr Pharm; 2007 Mar; 30(3):110-1. PubMed ID: 17405485
[No Abstract] [Full Text] [Related]
14. Intraoral delivery of antimicrobials.
Raj PA; Dentino AR
Drug News Perspect; 2005; 18(6):362-74. PubMed ID: 16247514
[TBL] [Abstract][Full Text] [Related]
15. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
Rhee MS; Greenblatt DJ
J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
[TBL] [Abstract][Full Text] [Related]
17. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
18. Re: "use of a Bayesian approach to decide when to stop a therapeutic trial: the case of a chemoprophylaxis trial in human immunodeficiency virus infection".
van Noord PA; van der Tweel I
Am J Epidemiol; 2005 Nov; 162(10):1033-5. PubMed ID: 16221807
[No Abstract] [Full Text] [Related]
19. 2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV.
Parris GE
Med Hypotheses; 2008; 70(4):776-82. PubMed ID: 17920779
[TBL] [Abstract][Full Text] [Related]
20. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
Wilson LE; Gallant JE
Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
